How Much MOTS-c Dosage Do Researchers Typically Use?

Research protocols for MOTS-c typically use 5 mg to 10 mg per week, split into 1 mg to 2 mg subcutaneous injections given daily or every other day. No human dose has been approved by the FDA, so every figure below comes from preclinical studies, vendor guides, or user logs. That means the question of how much MOTS-c dosage is appropriate has no evidence-based answer yet.

What Is MOTS-c and Why Dosing Is Uncertain

MOTS-c is a mitochondrial-derived peptide studied for its effects on metabolic signaling, insulin sensitivity, and cellular stress response. It is sold as a research chemical, which means there is no pharmacy insert, no standard dosing chart, and no approved human protocol.

Most laboratory work on MOTS-c uses rodents, and animal doses do not convert cleanly to human equivalents. That gap explains why researchers compare notes on forums and why dosage discussions vary so widely.

MOTS-c is not FDA-approved for human use in the United States, and all dosage information is experimental.

Typical MOTS-c Dosage Ranges Reported in Research

The numbers below reflect patterns in research forums, peptide vendor guides, and self-reported logs. They are anecdotal, not clinical recommendations.

Cycles usually run 4 to 12 weeks, with some users taking a 2- to 4-week break before repeating. No study confirms that cycling reduces risk.

MOTS-c vs. Other Metabolic Peptides

MOTS-c is often discussed alongside AOD-9604 and tesamorelin. A common search pattern is aod 9604 mots-c tesamorelin dosage, because all three are marketed for fat loss or metabolic support. Each peptide has a different reconstitution volume and injection schedule, so combining them requires separate math for each vial.

How to Calculate a MOTS-c Dose After Reconstitution

Dose math starts with the concentration you create when you add bacteriostatic water. A 10 mg vial mixed with 2 mL of water gives 5 mg per mL, so a 1 mg dose equals 0.2 mL, or 20 units on a U-100 insulin syringe. Using less water creates a stronger concentration and a smaller injection volume.

People who already know how much bac water to reconstitute peptides for other compounds can reuse the same formula here. The math behind how much bac water for 10mg bpc-157 follows an identical structure, even though the target dose is different. If you have used a calculator for how much bac water for peptides before, swap in the MOTS-c vial mass and your desired dose.

The same logic explains how much bac water to reconstitute 20mg tirzepatide: doubling the powder mass doubles the water needed to hold the same concentration, which changes the units drawn per dose.

Injection Frequency, Timing, and Cycle Length

MOTS-c is injected subcutaneously, most often into the abdomen or thigh. Reported schedules include:

• Daily: 1 mg to 2 mg each morning, sometimes fasted.
• Every other day: 2 mg to 2.5 mg per injection.
• Five days on, two off: 1 mg to 1.5 mg on training days.

Timing is frequently tied to exercise because MOTS-c is studied for its role in metabolic adaptation to physical activity. None of these schedules has been validated in human trials.

Most logs describe 4- to 12-week cycles. Users who track side effects often stop early when they notice fatigue, injection-site irritation, or changes in heart rate.

Side Effects and Safety Considerations

There is no long-term human safety data for MOTS-c. Side effects reported in user logs include:

• Redness, swelling, or itching at the injection site
• Headache or lightheadedness within an hour of dosing
• Fatigue, especially at higher weekly totals
• Appetite or blood sugar changes that may interact with diabetes medication

Anyone using insulin, metformin, or another glucose-lowering medication should not add MOTS-c without medical supervision. Mixing peptides at home also introduces risks of contamination and dosing errors.

Because MOTS-c is sold for research use only, it is not held to the purity and sterility standards required of prescription drugs.

Legal and Quality Considerations for Research Peptides

In the United States, MOTS-c is not an FDA-approved drug, and selling it for human consumption is illegal. Buyers take on the risk of unknown purity, incorrect peptide mass, and unsterile handling.

Third-party certificates of analysis help, but they are not a guarantee. Independent testing has found peptide vials with less peptide than the label claims, which makes any dosage calculation unreliable.

For anyone comparing options, the safest step is to talk with a physician who understands peptides, get baseline bloodwork, and avoid stacking multiple research compounds at once.

Bottom Line on MOTS-c Dosage

No established human dose of MOTS-c exists. Most reported protocols land between 5 mg and 10 mg per week, split into 1 mg to 2 mg injections, but those numbers come from anecdotal logs rather than clinical trials. Anyone researching this peptide should verify reconstitution math carefully, use sterile technique, and consult a healthcare professional before injecting an unapproved compound.